After serving at the helm of the U.S. Food and Drug Administration for six years, Commissioner Margaret A. Hamburg, MD, plans to step down at the end of March, according to a Reuters report. Dr.
November 18, 2011 — The US Food and Drug Administration (FDA) announced today that it is rescinding its approval of bevacizumab (Avastin, Genentech) for treating metastatic breast cancer because the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results